Ljung R - Search Results

1

Inhibitors in haemophilia A and B: Management of bleeds, inhibitor eradication and strategies for difficult-to-treat patients.

Ljung R, Auerswald G, Benson G, Dolan G, Duffy A, Hermans C, Jiménez-Yuste V, Lambert T, Morfini M, Zupančić-Šalek S, Santagostino E. Ljung R, et al. Eur J Haematol. 2019 Feb;102(2):111-122. doi: 10.1111/ejh.13193. Epub 2018 Dec 6. Eur J Haematol. 2019. PMID: 30411401 Free PMC article. Review.

2

Prenatal diagnosis of haemophilia.

Ljung RC. Ljung RC. Baillieres Clin Haematol. 1996 Jun;9(2):243-57. doi: 10.1016/s0950-3536(96)80061-8. Baillieres Clin Haematol. 1996. PMID: 8800503 Review.

3

Can haemophilic arthropathy be prevented?

Ljung RC. Ljung RC. Br J Haematol. 1998 May;101(2):215-9. doi: 10.1046/j.1365-2141.1998.00707.x. Br J Haematol. 1998. PMID: 9609513 Free article. Review. No abstract available.

4

Breastfeeding does not influence the development of inhibitors in haemophilia.

Knobe KE, Tengborn LI, Petrini P, Ljung RC. Knobe KE, et al. Among authors: ljung rc. Haemophilia. 2002 Sep;8(5):657-9. doi: 10.1046/j.1365-2516.2002.00655.x. Haemophilia. 2002. PMID: 12199675

5

Inhibitors in the Swedish population with severe haemophilia A and B: a 20-year survey.

Knobe KE, Sjörin E, Tengborn LI, Petrini P, Ljung RC. Knobe KE, et al. Among authors: ljung rc. Acta Paediatr. 2002;91(8):910-4. doi: 10.1080/080352502760148621. Acta Paediatr. 2002. PMID: 12222714

6

Consensus perspectives on prophylactic therapy for haemophilia: summary statement.

Berntorp E, Astermark J, Björkman S, Blanchette VS, Fischer K, Giangrande PL, Gringeri A, Ljung RC, Manco-Johnson MJ, Morfini M, Kilcoyne RF, Petrini P, Rodriguez-Merchan EC, Schramm W, Shapiro A, van den Berg HM, Hart C. Berntorp E, et al. Among authors: ljung rc. Haemophilia. 2003 May;9 Suppl 1:1-4. doi: 10.1046/j.1365-2516.9.s1.17.x. Haemophilia. 2003. PMID: 12709030

7

Intracranial haemorrhage in haemophilia A and B.

Ljung RC. Ljung RC. Br J Haematol. 2008 Feb;140(4):378-84. doi: 10.1111/j.1365-2141.2007.06949.x. Epub 2007 Dec 13. Br J Haematol. 2008. PMID: 18081890 Free article. Review.

8

Secondary prophylaxis with recombinant activated factor VII improves health-related quality of life of haemophilia patients with inhibitors.

Hoots WK, Ebbesen LS, Konkle BA, Auerswald GK, Roberts HR, Weatherall J, Ferran JM, Ljung RC; Novoseven (F7HAEM-1505) Investigators. Hoots WK, et al. Among authors: ljung rc. Haemophilia. 2008 May;14(3):466-75. doi: 10.1111/j.1365-2516.2008.01654.x. Epub 2008 Feb 12. Haemophilia. 2008. PMID: 18282155

9

Paediatric haemophilia with inhibitors: existing management options, treatment gaps and unmet needs.

Santagostino E, Morfini M, Auerswald GK, Benson GM, Salek SZ, Lambert T, Salaj P, Jimenez-Yuste V, Ljung RC. Santagostino E, et al. Among authors: ljung rc. Haemophilia. 2009 Sep;15(5):983-9. doi: 10.1111/j.1365-2516.2009.01999.x. Haemophilia. 2009. PMID: 19712172 Review.

10

The need for speed in the management of haemophilia patients with inhibitors.

Salek SZ, Benson GM, Elezović I, Krenn V, Ljung RC, Morfini M, Remor E, Santagostino E, Sørensen B. Salek SZ, et al. Among authors: ljung rc. Haemophilia. 2011 Jan;17(1):95-102. doi: 10.1111/j.1365-2516.2010.02265.x. Haemophilia. 2011. PMID: 20398071

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

413 results

Search Page